
In a world heavily focused on therapeutic options for multidrug-resistant gram-negative organisms, the emergence of antimicrobial resistance among enterococci is often an under-recognized risk.
Walsh is an infectious diseases clinical pharmacy specialist and the pharmacy lead for the Antimicrobial Stewardship Program at Roswell Park Comprehensive Cancer Center in Buffalo, New York. Her research interests include antimicrobial stewardship in the immunocompromised host, including data-driven quality and process improvement.

In a world heavily focused on therapeutic options for multidrug-resistant gram-negative organisms, the emergence of antimicrobial resistance among enterococci is often an under-recognized risk.